Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023)
Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
7,249.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-191.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
6,026.00 |
| Sep 30, 2023 |
978.00 |
| Jun 30, 2023 |
17,003.00 |
| Mar 31, 2023 |
-23,111.00 |
| Dec 31, 2022 |
2,805.00 |
| Sep 30, 2022 |
-15,957.00 |
| Jun 30, 2022 |
4,557.00 |
| Mar 31, 2022 |
-4,151.00 |
| Dec 31, 2021 |
-2,621.00 |
| Sep 30, 2021 |
-1,503.00 |
| Jun 30, 2021 |
-9,847.00 |
| Mar 31, 2021 |
-9,957.00 |
| Dec 31, 2020 |
-10,649.00 |
| Sep 30, 2020 |
-11,726.00 |
| Jun 30, 2020 |
-23,026.00 |
| Mar 31, 2020 |
-16.00 |
| Dec 31, 2019 |
-12,464.00 |
| Sep 30, 2019 |
-4,704.00 |
| Jun 30, 2019 |
-6,914.00 |
| Mar 31, 2019 |
-5,201.00 |
